Combinatorial Targeting of ATF5 and the PI3K/mTOR Signaling Pathway as a Therapeutic Strategy for Glioblastoma

被引:0
|
作者
Chau, Lily
Karpel-Massler, Georg
Shu, Chang
Angelastro, James
Greene, Lloyd
Siegelin, Markus
机构
[1] Columbia Univ, New York, NY USA
[2] UC Davis Sch Vet Med, Davis, CA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1716
引用
收藏
页码:429A / 430A
页数:2
相关论文
共 50 条
  • [21] Targeting PI3K/mTOR signaling in cutaneous angiosarcoma
    Wada, M.
    Horinaka, M.
    Sakai, T.
    Masuzawa, M.
    Katoh, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S56 - S56
  • [22] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [23] Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
    Zhou, S.
    Liu, L.
    Li, H.
    Eilers, G.
    Kuang, Y.
    Shi, S.
    Yan, Z.
    Li, X.
    Corson, J. M.
    Meng, F.
    Zhou, H.
    Sheng, Q.
    Fletcher, J. A.
    Ou, W-B
    BRITISH JOURNAL OF CANCER, 2014, 110 (10) : 2479 - 2488
  • [24] DUAL TARGETING OF PI3K AND mTOR SIGNALING IN MEDULLOBLASTOMA
    Clymer, Jessica
    Eckerdt, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2016, 18 : 112 - 112
  • [25] Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
    S Zhou
    L Liu
    H Li
    G Eilers
    Y Kuang
    S Shi
    Z Yan
    X Li
    J M Corson
    F Meng
    H Zhou
    Q Sheng
    J A Fletcher
    W-B Ou
    British Journal of Cancer, 2014, 110 : 2479 - 2488
  • [26] Targeting the PI3K/mTOR pathway hematologic malignancies
    Tasian, Sarah K.
    Teachey, David T.
    Rheingold, Susan R.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [27] Targeting the PI3K signaling pathway in cancer
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    Cantley, Lewis C.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2010, 20 (01) : 87 - 90
  • [28] RAS Signaling in the PI3K/AKT/MTOR Pathway
    Nussinov, Ruth
    Zhang, Mingzhen
    Jang, Hyunbum
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 51A - 51A
  • [29] The PI3K/mTOR PATHWAY CONTRIBUTES TO SEX DIFFERENCES IN GLIOBLASTOMA
    Sponagel, Jasmin
    Yu, Kwanha
    Deneen, Benjamin
    Ippolito, Joseph
    Rubin, Joshua
    NEURO-ONCOLOGY, 2018, 20 : 37 - 37
  • [30] Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway
    Liu, Ming
    Wang, Jiwei
    Qi, Qichao
    Huang, Bin
    Chen, Anjing
    Li, Xingang
    Wang, Jian
    ONCOLOGY REPORTS, 2016, 36 (04) : 2160 - 2168